<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Nonconvulsive status epilepticus: Classification, clinical features, and diagnosis
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Nonconvulsive status epilepticus: Classification, clinical features, and diagnosis
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Nonconvulsive status epilepticus: Classification, clinical features, and diagnosis
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Jeffrey Jirsch, MD, MSc., FRCPC
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Lawrence J Hirsch, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Paul Garcia, MD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Alejandro A Rabinstein, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            John F Dashe, MD, PhD
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Sep 25, 2023.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H22466480">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Nonconvulsive status epilepticus (NCSE) was originally described in patients with chronic epilepsy, but it is now recognized with increased frequency in other patient populations, especially the critically ill. The diagnosis and treatment of NCSE are not straightforward and depend on many variables, including the clinical setting and etiology, electroencephalography (EEG) findings, and the clinical status of the patient. In addition, it is not always clear to what extent the electrographic activity contributes to clinical impairment or ongoing neuronal injury.
        </p>
        <p>
         This topic reviews the classification, etiology, clinical features, and diagnosis of NCSE. Treatment and outcomes are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/129547.html" rel="external">
          "Nonconvulsive status epilepticus: Treatment and prognosis"
         </a>
         .)
        </p>
        <p>
         Convulsive status epilepticus is reviewed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/2217.html" rel="external">
          "Convulsive status epilepticus in adults: Classification, clinical features, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/96933.html" rel="external">
          "Convulsive status epilepticus in adults: Management"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6222.html" rel="external">
          "Clinical features and complications of status epilepticus in children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6192.html" rel="external">
          "Management of convulsive status epilepticus in children"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H327107905">
         <span class="h1">
          DEFINITION
         </span>
         <span class="headingEndMark">
          —
         </span>
         The International League Against Epilepsy (ILAE) defines status epilepticus as a condition resulting either from the failure of the mechanisms responsible for seizure termination or from the initiation of mechanisms that lead to abnormally prolonged seizures [
         <a href="#rid1">
          1
         </a>
         ]. The temporal threshold that defines an abnormally prolonged seizure depends on the type of seizure. For convulsive status epilepticus, this duration is five minutes. For NCSE, defined as status epilepticus without prominent motor symptoms, the threshold is 10 minutes.
        </p>
        <p>
         Not included in these definitions, but still widely used by clinicians, is the situation in which brief intermittent seizure activity without convulsions occurs without full recovery of consciousness between attacks [
         <a href="#rid1">
          1,2
         </a>
         ]. In patients with baseline coma or encephalopathy, NCSE was defined by the American Clinical Neurophysiology Society (ACNS) as ictal activity constituting &gt;20 percent of an hour of recording (ie, &gt;12 mins) [
         <a href="#rid3">
          3
         </a>
         ]. This is based on evidence that the risk of neurological decline increases substantially if the maximal hourly seizure burden is &gt;20 percent [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p>
         According to ACNS terminology, NCSE in the critically ill patient can be divided into electrographic status epilepticus (with or without a clinical correlate) and electroclinical status epilepticus (when a clinical correlate can be demonstrated, even if subtle) [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H103541780">
         <span class="h1">
          ETIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         The underlying causes of NCSE are varied and differ according to the patient population being studied (eg, ambulatory versus critically ill). Approximately one-half to two-thirds of patients will have a prior history of seizures or epilepsy.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Absence SE
         </strong>
         – Typical and atypical absence status epilepticus (ASE) occurs without coma primarily in children with genetic generalized epilepsy in which absence seizures occur (previously termed idiopathic generalized epilepsies) or in infants and children with epileptic encephalopathies, as discussed above. De novo ASE is a rare type of NCSE that can present in older adults without coma or a prior history of epilepsy; the condition in most cases is triggered by alcohol abuse, psychotropic drug initiation, or benzodiazepine withdrawal [
         <a href="#rid5">
          5
         </a>
         ] but can also be represent a late-onset idiopathic generalized epilepsy [
         <a href="#rid6">
          6
         </a>
         ]. (See
         <a class="local">
          'Typical absence SE'
         </a>
         below and
         <a class="local">
          'Atypical absence SE'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Infectious or autoimmune encephalitis
         </strong>
         – NCSE can be the presenting symptom of infectious or autoimmune encephalitis [
         <a href="#rid7">
          7-12
         </a>
         ]. Conditions associated with the presence of a supernumerary ring chromosome (most frequently ring chromosome 20) can present with episodes of focal status epilepticus of frontal origin. These episodes are often subtle, manifesting only as mental slowing, and can last for hours or even days [
         <a href="#rid13">
          13
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Focal epilepsy
         </strong>
         – The causes of NCSE in patients with known focal seizures are the same as the underlying causes of focal epilepsy, such as mesial temporal sclerosis, structural-metabolic causes (eg, malformations of cortical development, tumors, head trauma, stroke, vascular malformations), and various genetic focal epilepsies. Common precipitants include alcohol or antiseizure medication withdrawal, infections, sleep deprivation, and toxic or metabolic disturbances. (See
         <a class="medical medical_review" href="/z/d/html/2231.html" rel="external">
          "Focal epilepsy: Causes and clinical features", section on 'Etiologies'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Aftermath of convulsive status epilepticus
         </strong>
         – The underlying etiologies for NCSE in the aftermath of convulsive status epilepticus are similar to the causes of convulsive seizure in these patients. These include antiseizure medication nonadherence or discontinuation, other drug withdrawal syndromes, acute structural brain injury or infection, remote structural brain injury, metabolic derangements, and chronic epilepsy. (See
         <a class="medical medical_review" href="/z/d/html/2217.html" rel="external">
          "Convulsive status epilepticus in adults: Classification, clinical features, and diagnosis", section on 'Etiology'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Central nervous system or systemic illness
         </strong>
         – In critically ill patients found to have NCSE, common underlying diagnoses include subarachnoid hemorrhage, epilepsy, central nervous system infection, brain tumor, ischemic or hemorrhagic stroke, traumatic brain injury, hypoxia/anoxia, and toxic-metabolic disturbance, including sepsis [
         <a href="#rid14">
          14-19
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Drug-induced
         </strong>
         – Drug-induced NCSE is an important consideration in critically ill patients as well as cancer patients being treated with multiagent chemotherapy. NCSE due to beta-lactam antibiotics, particularly
         <a class="drug drug_general" data-topicid="9215" href="/z/d/drug information/9215.html" rel="external">
          cefepime
         </a>
         , has been well described, most often in association with renal dysfunction [
         <a href="#rid20">
          20-24
         </a>
         ]. Other drugs that have been associated with NCSE include fluoroquinolones [
         <a href="#rid25">
          25
         </a>
         ],
         <a class="drug drug_general" data-topicid="8552" href="/z/d/drug information/8552.html" rel="external">
          ifosfamide
         </a>
         [
         <a href="#rid26">
          26
         </a>
         ], L-asparaginase [
         <a href="#rid27">
          27
         </a>
         ],
         <a class="drug drug_general" data-topicid="9271" href="/z/d/drug information/9271.html" rel="external">
          cisplatin
         </a>
         [
         <a href="#rid28">
          28
         </a>
         ], and
         <a class="drug drug_general" data-topicid="9173" href="/z/d/drug information/9173.html" rel="external">
          busulfan
         </a>
         . In some cases, NCSE is a presentation of drug-induced posterior reversible encephalopathy syndrome (PRES) [
         <a href="#rid29">
          29
         </a>
         ]; among the more common culprits are
         <a class="drug drug_general" data-topicid="9217" href="/z/d/drug information/9217.html" rel="external">
          cyclosporine
         </a>
         ,
         <a class="drug drug_general" data-topicid="9971" href="/z/d/drug information/9971.html" rel="external">
          tacrolimus
         </a>
         , and agents that target angiogenesis (eg,
         <a class="drug drug_general" data-topicid="8683" href="/z/d/drug information/8683.html" rel="external">
          bevacizumab
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/479.html" rel="external">
          "Beta-lactam antibiotics: Mechanisms of action and resistance and adverse effects", section on 'Neurologic reactions'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2836.html" rel="external">
          "Overview of neurologic complications of conventional non-platinum cancer chemotherapy"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/4835.html" rel="external">
          "Reversible posterior leukoencephalopathy syndrome", section on 'Related conditions'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Withdrawal from benzodiazepines, opioids, and
         <a class="drug drug_general" data-topicid="9062" href="/z/d/drug information/9062.html" rel="external">
          baclofen
         </a>
         has also been associated with NCSE [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          New-onset refractory status epilepticus
         </strong>
         – New-onset refractory status epilepticus (NORSE) refers to a clinical presentation, not a specific diagnosis, of refractory status epilepticus (RSE) for which no etiology is identified within the first 72 hours after admission in a patient without active epilepsy or other preexisting, relevant neurologic disorder [
         <a href="#rid31">
          31
         </a>
         ]. NORSE makes up less than 10 percent of patients presenting with status epilepticus but a higher proportion of patents with refractory NCSE [
         <a href="#rid32">
          32-34
         </a>
         ]. A cause for NORSE  (
         <a class="graphic graphic_table graphicRef140710" href="/z/d/graphic/140710.html" rel="external">
          table 1
         </a>
         ) is ultimately found in up to one-half of patients, most frequently an autoimmune or paraneoplastic encephalitis (eg, NORSE due to anti-NMDA receptor encephalitis). When no underlying cause is identified, the situation is referred to as cryptogenic NORSE or NORSE of unknown etiology [
         <a href="#rid32">
          32
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3435380341">
         <span class="h1">
          CLINICAL FEATURES
         </span>
         <span class="headingEndMark">
          —
         </span>
         Impairment of consciousness ranging from mild confusion to coma is usually present in NCSE; focal status epilepticus without impairment in consciousness is less common.
        </p>
        <p>
         Other clinical features of NCSE can vary widely and are often divided into two general categories: negative symptoms, which are impairments such as aphasia, mutism, amnesia and catatonia, and positive phenomenology, such as rhythmic twitching of one or more muscle groups, tonic eye deviation, hippus, or nystagmoid eye jerking. A list of negative and positive symptoms seen in NCSE is found in the table  (
         <a class="graphic graphic_table graphicRef88652" href="/z/d/graphic/88652.html" rel="external">
          table 2
         </a>
         ). Positive symptoms are often subtle and can be overlooked.
        </p>
        <p>
         Some patients will have no manifestations of ongoing seizures other than coma, even when scrutinized by experienced clinicians. In fact, approximately three-quarters of critically ill patients with nonconvulsive seizures or NCSE will have no discernible clinical correlate and require EEG monitoring for diagnosis [
         <a href="#rid35">
          35,36
         </a>
         ].
        </p>
        <p>
         Clinical features associated with specific types of NCSE are discussed in more detail in the sections below.
        </p>
        <p class="headingAnchor" id="H22466573">
         <span class="h1">
          ELECTROCLINICAL CLASSIFICATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         In the International League Against Epilepsy (ILAE) classification, NCSE is subdivided according to the level of consciousness and clinical and EEG features [
         <a href="#rid1">
          1
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/2220.html" rel="external">
          "Overview of the management of epilepsy in adults", section on 'Classification'
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          NCSE without coma
         </strong>
         :
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Generalized NCSE
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Typical absence status epilepticus (ASE)
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Atypical ASE
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Myoclonic ASE
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Focal NCSE
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         With impairment of consciousness
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Without impairment of consciousness
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Aphasic status epilepticus
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Unknown whether focal or generalized NCSE
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Autonomic status epilepticus
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          NCSE with coma
         </strong>
        </p>
        <p>
        </p>
        <p>
         In addition, there are so-called "boundary conditions" that show evidence of ongoing electrographic epileptiform activity but lack clinical symptomatology that would conventionally be considered epileptic [
         <a href="#rid37">
          37
         </a>
         ]. (See
         <a class="local">
          'Boundary conditions'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H1610007814">
         <span class="h2">
          NCSE without coma
         </span>
        </p>
        <p class="headingAnchor" id="H369189049">
         <span class="h3">
          Generalized NCSE
         </span>
        </p>
        <p class="headingAnchor" id="H28783851">
         <span class="h4">
          Typical absence SE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Typical ASE is a form of primary generalized NCSE that is almost always seen in patients with known genetic generalized epilepsy (previously known as idiopathic generalized epilepsy). Clinical features include confusion, behavioral arrest, staring, slowed thinking, repeated blinking, and impaired alertness [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p>
         Typical ASE has a characteristic EEG pattern of bilaterally synchronous spike-and-wave discharges occurring at a rate of 2.5 to 5 Hz (most commonly 3 Hz)  (
         <a class="graphic graphic_waveform graphicRef88644" href="/z/d/graphic/88644.html" rel="external">
          waveform 1
         </a>
         ).
        </p>
        <p>
         ASE is uncommon but can occur in those patients with epilepsy syndromes in which typical absence seizures occur (ie, childhood absence, juvenile absence, or juvenile myoclonic epilepsy) [
         <a href="#rid39">
          39
         </a>
         ]. In some cases, ASE may be precipitated by the use of an inappropriate antiseizure medication in a patient with genetic generalized epilepsy (most commonly
         <a class="drug drug_general" data-topicid="9198" href="/z/d/drug information/9198.html" rel="external">
          carbamazepine
         </a>
         , but also
         <a class="drug drug_general" data-topicid="9467" href="/z/d/drug information/9467.html" rel="external">
          oxcarbazepine
         </a>
         and
         <a class="drug drug_general" data-topicid="9769" href="/z/d/drug information/9769.html" rel="external">
          phenytoin
         </a>
         ) [
         <a href="#rid40">
          40
         </a>
         ]. There are also rare cases of de novo ASE in older adults presenting with confusion ranging from slight disorientation to fluctuating stupor and with duration of such states varying from hours to weeks. Cases are most often linked to withdrawal of benzodiazepines, alcohol abuse, or initiation of psychotropic medications [
         <a href="#rid5">
          5,41
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H28783858">
         <span class="h4">
          Atypical absence SE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Atypical ASE is a form of generalized NCSE that has a slower spike-and-wave discharge pattern than typical absence status, approximately 1 to 2.5 Hz. This typically occurs in infants and children with epileptic encephalopathies, including Lennox-Gastaut syndrome. Clinical features include behavioral changes and altered awareness, though the onset and cessation are less apparent than with typical absence SE [
         <a href="#rid38">
          38
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/138854.html" rel="external">
          "Lennox-Gastaut syndrome"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1042785500">
         <span class="h4">
          Myoclonic absence SE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Myoclonic ASE is very rare. It occurs most often in genetic generalized epilepsy. Seizures are just like absence (with sudden onset of staring and impaired alertness and generalized spike-wave EEG), but with myoclonic jerks time-locked to each spike-wave discharge. The myoclonus is usually fairly subtle, involving the eyelid or perioral musculature, but it can also be evident in axial or limb muscles.
        </p>
        <p class="headingAnchor" id="H3127493001">
         <span class="h3">
          Focal NCSE
         </span>
        </p>
        <p class="headingAnchor" id="H15026272">
         <span class="h4">
          Focal SE without impairment of consciousness
         </span>
         <span class="headingEndMark">
          —
         </span>
         Focal status epilepticus without impairment of consciousness (often still referred to as simple partial status epilepticus using the older terminology) is relatively uncommon and generally arises in patients with established focal epilepsy. Such patients have positive or negative symptomatology with preserved awareness with or without focal ictal activity on EEG; approximately half will not have a clear scalp EEG correlate.
        </p>
        <p>
         Symptoms are varied (eg, focal clonic jerking, head and eye deviation, hemiparesis, hemisensory changes, aphasia, alien hand syndrome, hemispatial neglect, or other visual, auditory, olfactory, gustatory, autonomic, and/or cognitive changes), depending largely on the cerebral localization of the discharges [
         <a href="#rid30">
          30,38
         </a>
         ]. When subjective sensory or experiential phenomena are involved, this form of NCSE is known as "aura continua" [
         <a href="#rid42">
          42
         </a>
         ]. When continuous focal motor activity is involved with fully retained awareness, it is referred to as epilepsia partialis continua [
         <a href="#rid43">
          43
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/2217.html" rel="external">
          "Convulsive status epilepticus in adults: Classification, clinical features, and diagnosis", section on 'Focal motor status epilepticus'
         </a>
         .)
        </p>
        <p>
         Sudden-onset aphasia, usually mixed, can be the only manifestation of a language-dominant hemispheric NCSE, a condition known as aphasic status epilepticus.
        </p>
        <p class="headingAnchor" id="H28783865">
         <span class="h4">
          Focal SE with impairment of consciousness
         </span>
         <span class="headingEndMark">
          —
         </span>
         Prolonged focal seizures with impairment of consciousness or awareness in
         <strong>
          non-comatose
         </strong>
         patients with chronic focal epilepsy or a focal acute brain injury are a form of NCSE; these were previously referred to as complex partial status epilepticus and are more appropriately referred to as focal status epilepticus with impaired awareness. Seizures most commonly originate from the temporal or frontal lobe. In addition to impaired consciousness, manifestations can include confusion, other altered mental status, aphasia, amnesia, behavioral changes, and automatisms [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p>
         EEG typically reveals focal discharges localized to the temporal or frontal lobe or generalized discharges indistinguishable from generalized-onset NCSE. Less commonly, there are no detectable EEG findings if the ictal activity is confined to deep structures [
         <a href="#rid44">
          44
         </a>
         ]. This type of status epilepticus is most common in adults, usually with a history of focal epilepsy, who are being evaluated for impaired consciousness or prolonged postictal confusion [
         <a href="#rid45">
          45
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H542486148">
         <span class="h2">
          NCSE in coma
         </span>
         <span class="headingEndMark">
          —
         </span>
         A substantial number of critically ill comatose children and adults in intensive care units (ICUs) who are monitored with EEG are found to have nonconvulsive seizures and/or NCSE. The clinical features in a comatose patient may include nystagmus, myoclonus, or gaze deviation, although the majority of patients have no evident signs other than coma [
         <a href="#rid38">
          38
         </a>
         ]. Approximately 8 to 20 percent of comatose patients who have not had any clinical seizure activity will have EEG findings consistent with NCSE at the time of monitoring [
         <a href="#rid4">
          4,14-19,46-56
         </a>
         ].
        </p>
        <p>
         Risk factors for NCSE in the critically ill include severe alteration of consciousness (ie, coma), clinical seizures prior to monitoring, younger age (especially children), history of epilepsy or remote brain injury, recent neurosurgical procedure, acute brain injury, intracranial tumor, and sepsis [
         <a href="#rid14">
          14-16,18,19,46,47,55-59
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H936096898">
         <span class="h2">
          Aftermath of convulsive SE
         </span>
         <span class="headingEndMark">
          —
         </span>
         Some patients treated for generalized convulsive status epilepticus are noted to have continuous ictal EEG activity after cessation of movements [
         <a href="#rid60">
          60-62
         </a>
         ]. In one prospective study, NCSE was present in 14 percent of 164 patients monitored after treatment for convulsive status epilepticus; an additional 34 percent had intermittent ictal discharges that did not meet criteria for status epilepticus [
         <a href="#rid60">
          60
         </a>
         ].
        </p>
        <p>
         In some cases, NCSE can occur after a single brief convulsive seizure, taking the form of a prolonged confusional state that is sometimes mistakenly thought to be postictal. Some use the term "subtle status epilepticus" for this specific scenario of periodic discharges or NCSE after convulsive status epilepticus, but this term is used less specifically in other instances. We prefer the term "status epilepticus terminans" when there are periodic discharges after convulsive seizures or convulsive status epilepticus, using the term "subtle status epilepticus" more broadly, as the name implies, for any form of status epilepticus with subtle or no clinical manifestations [
         <a href="#rid63">
          63
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H28783642">
         <span class="h2">
          Boundary conditions
         </span>
         <span class="headingEndMark">
          —
         </span>
         In addition to the above subtypes, NCSE also takes on distinct forms in early childhood, in the aftermath of generalized convulsive status epilepticus, and in the critically ill and/or comatose patient.
        </p>
        <p class="headingAnchor" id="H4073668">
         <span class="h3">
          Neonatal and infantile epileptic encephalopathy
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are a number of severe epileptic syndromes occurring primarily in the neonatal and infantile periods that take the form of continuous or near-continuous episodes of NCSE. These include some cases of West syndrome, Ohtahara syndrome, Dravet syndrome, and Lennox-Gastaut syndrome [
         <a href="#rid37">
          37
         </a>
         ]. These conditions are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/108278.html" rel="external">
          "Dravet syndrome: Genetics, clinical features, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/139238.html" rel="external">
          "Overview of infantile epilepsy syndromes", section on 'Developmental and epileptic encephalopathies'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/138854.html" rel="external">
          "Lennox-Gastaut syndrome"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H784277">
         <span class="h3">
          Electrical status epilepticus of sleep
         </span>
         <span class="headingEndMark">
          —
         </span>
         Electrical status epilepticus of sleep (ESES) is a rare form of NCSE characterized by the presence of 1 to 3 Hz spike-wave discharges occupying over 80 percent or more of the EEG during non-rapid eye movement (non-REM) sleep. Many children with ESES exhibit symptoms of Landau-Kleffner syndrome, a rare syndrome characterized by progressive loss of language beginning at approximately three to six years of age. ESES is also the cardinal EEG finding in the syndrome of epileptic encephalopathy with continuous spikes and waves during sleep (CSWS). ESES has also been observed in association with other childhood electroclinical syndromes such as Lennox-Gastaut syndrome and benign epilepsy with centrotemporal spikes. These conditions are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6162.html" rel="external">
          "Epilepsy syndromes in children", section on 'Developmental and epileptic encephalopathy with spike-wave activation in sleep (DEE-SWAS)'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6158.html" rel="external">
          "Self-limited focal epilepsies of childhood", section on 'Self-limited epilepsy with centrotemporal spikes (SeLECTS)'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/138854.html" rel="external">
          "Lennox-Gastaut syndrome"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H795799703">
         <span class="h3">
          Coma or acute confusional states with epileptiform EEG patterns
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are several clinical situations in which there is evidence of ongoing focal or generalized epileptiform activity by EEG, but in which the relationship of the EEG findings to the clinical scenario is not fully understood or agreed upon. In some cases, the controversy arises because of a lack of agreement as to whether the EEG changes are causative of the clinical condition or symptomatic of it. Such conditions include some cases of coma due to acute brain injury, some cases of epileptic behavioral disturbance or psychosis, and some cases of drug-induced or metabolic confusional states, often with myoclonic jerks, with evidence of epileptiform changes on EEG [
         <a href="#rid37">
          37
         </a>
         ]. (See
         <a class="local">
          'Uncertain EEG patterns in critical illness'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H4214127798">
         <span class="h1">
          EVALUATION
         </span>
        </p>
        <p class="headingAnchor" id="H2563126299">
         <span class="h2">
          When to suspect NCSE
         </span>
         <span class="headingEndMark">
          —
         </span>
         NCSE is much more common than previously recognized, particularly in intensive care unit (ICU) patients, and the diagnosis requires a high index of suspicion. As a general rule, any fluctuating or unexplained alteration in behavior or mental status warrants consideration of NCSE and evaluation with EEG, as does any acute supratentorial brain injury with altered level of consciousness. The indications for EEG are discussed in greater detail below. (See
         <a class="local">
          'Patient selection for EEG'
         </a>
         below.)
        </p>
        <p>
         No single clinical symptom has been shown to be specific for a diagnosis of NCSE in patients with an acute change in mental status. In general, NCSE is more common with severe depression in consciousness (coma) than with milder alterations. Additional factors that increase the likelihood of nonconvulsive seizures or NCSE in a patient with altered mental state include ocular movement abnormalities (sustained eye deviation, nystagmus); risk factors for seizure, including a history of epilepsy; convulsive seizure during the current illness; and age less than one year [
         <a href="#rid14">
          14,45,52,64
         </a>
         ]. Automatisms such as lip smacking and subtle motor twitches in the face or extremities can be manifestations of NCSE but have low specificity (44 percent in one study); ocular movement abnormalities were a more specific finding (86 percent) in this study [
         <a href="#rid45">
          45
         </a>
         ]. Another study found that facial/periorbital twitching was more likely to be associated with electrographic seizures than other clinical spells or movements in the critically ill [
         <a href="#rid65">
          65
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1810589497">
         <span class="h2">
          History and examination
         </span>
         <span class="headingEndMark">
          —
         </span>
         The history in patients with possible NCSE should review the patient's baseline neurologic function and possible causes of altered mental status, including risk factors for NCSE [
         <a href="#rid30">
          30
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Abrupt change in mental status, including new-onset psychosis in patients without a psychiatric history, or sudden worsening of a known psychiatric condition, particularly if associated with a recent change in medications or dosing (eg, abrupt withdrawal of benzodiazepine, initiation of antipsychotic such as
         <a class="drug drug_general" data-topicid="9289" href="/z/d/drug information/9289.html" rel="external">
          clozapine
         </a>
         or antidepressant such as
         <a class="drug drug_general" data-topicid="9171" href="/z/d/drug information/9171.html" rel="external">
          bupropion
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         History of trauma, infection, or recent illness
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         History of seizures or epilepsy, and possible nonadherence with antiseizure medication treatment
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         History of substance abuse
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Remote or chronic risk factors for seizure (eg, moderate to severe traumatic brain injury, stroke, meningitis, encephalitis, brain tumor, neurosurgery, dementia)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prior episodes of stereotypic events (eg, prolonged staring spells, psychotic behavior)
        </p>
        <p>
        </p>
        <p>
         The examination should look for evidence of findings associated with seizures or NCSE [
         <a href="#rid30">
          30
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Fever (although lacks sensitivity and specificity for NCSE)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Head trauma
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Tongue bite or laceration
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Posterior shoulder dislocation (see
         <a class="medical medical_review" href="/z/d/html/258.html" rel="external">
          "Shoulder dislocation and reduction", section on 'Posterior shoulder dislocation'
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Urinary incontinence
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Abnormal eye movements (eg, nystagmus) or hippus
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sustained head and eye deviation
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hemispatial neglect
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Focal myoclonus of the face or limbs
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Automatisms (repetitive stereotypic, purposeless movements including lip smacking, orofacial twitching, arm and hand movements such as picking or fidgeting)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3011159863">
         <span class="h2">
          Laboratory studies
         </span>
         <span class="headingEndMark">
          —
         </span>
         A number of studies are important in the evaluation for the cause of seizures, though not specific for identifying NCSE with the exception of EEG:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Rapid point-of-care blood glucose should be checked urgently to exclude hypoglycemia in all patients with acute change in mental status or suspected seizure.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Other laboratory studies that are appropriate include electrolytes, calcium (total and ionized), magnesium, complete blood count, renal function tests, liver function tests, urinalysis, and urine toxicology screen. Serum antiseizure medication levels should be added for patients with known epilepsy on therapy. A pregnancy test in women of childbearing age is commonly performed, as pregnancy may affect testing and treatment decisions. In patients with refractory status epilepticus or new onset of frequent seizures, we routinely check pyridoxine, since low pyridoxine levels can exacerbate seizures, and pyridoxine levels are often low in these patients; the majority of 81 adults with status epilepticus were deficient in one study [
         <a href="#rid66">
          66
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Neuroimaging is indicated in all patients with unexplained change in mental status. (See
         <a class="local">
          'Neuroimaging'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lumbar puncture is indicated in select patients, as discussed below. (See
         <a class="local">
          'Lumbar puncture'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         EEG is essential to the evaluation of all patients with suspected NCSE. (See
         <a class="local">
          'Electroencephalography'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p>
         When there is a high clinical suspicion for bacterial meningitis or encephalitis, treatment with
         <a class="drug drug_general" data-topicid="9334" href="/z/d/drug information/9334.html" rel="external">
          dexamethasone
         </a>
         and antimicrobial agents should be given prior to neuroimaging studies and lumbar puncture. (See
         <a class="medical medical_review" href="/z/d/html/1287.html" rel="external">
          "Clinical features and diagnosis of acute bacterial meningitis in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1290.html" rel="external">
          "Initial therapy and prognosis of community-acquired bacterial meningitis in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1299.html" rel="external">
          "Dexamethasone to prevent neurologic complications of bacterial meningitis in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5968.html" rel="external">
          "Bacterial meningitis in children older than one month: Clinical features and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6010.html" rel="external">
          "Bacterial meningitis in children older than one month: Treatment and prognosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6026.html" rel="external">
          "Bacterial meningitis in children: Dexamethasone and other measures to prevent neurologic complications"
         </a>
         .)
        </p>
        <p>
         Other investigations (eg, polymerase chain reaction of cerebrospinal fluid for herpes simplex virus; paraneoplastic and/or autoimmune antibodies) may be indicated in select patients if there is suspicion for infectious, paraneoplastic, or autoimmune encephalitis as the cause of NCSE. These conditions are discussed elsewhere. (See
         <a class="medical medical_review" href="/z/d/html/1284.html" rel="external">
          "Viral encephalitis in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/6042.html" rel="external">
          "Acute viral encephalitis in children: Clinical manifestations and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/8278.html" rel="external">
          "Herpes simplex virus type 1 encephalitis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/15759.html" rel="external">
          "Autoimmune (including paraneoplastic) encephalitis: Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1535928620">
         <span class="h2">
          Neuroimaging
         </span>
         <span class="headingEndMark">
          —
         </span>
         All patients with unexplained change in mental status should have urgent neuroimaging. Neuroimaging with computed tomography (CT) or magnetic resonance imaging (MRI) is useful to identify common causes of NCSE such as stroke, tumor, traumatic brain injury, infection, or inflammation. (See
         <a class="medical medical_review" href="/z/d/html/4824.html" rel="external">
          "Diagnosis of delirium and confusional states", section on 'Neuroimaging'
         </a>
         .)
        </p>
        <p>
         While useful for identifying certain conditions that may cause NCSE, conventional structural brain imaging is imperceptive of seizure activity per se and is of no use for the diagnosis of NCSE. However, diffusion, perfusion, and metabolic MRI techniques may reveal indirect signs of prolonged, and potentially harmful, neuronal hyperactivity (see
         <a class="medical medical_review" href="/z/d/html/2234.html" rel="external">
          "Magnetic resonance imaging changes related to acute seizure activity"
         </a>
         ). Positron emission tomography (PET) can also identify neuronal hypermetabolism associated with NCSE. Perfusion CT imaging may help differentiate stroke from focal seizure activity in some cases.
        </p>
        <p>
         Examples of such signs include focal restricted diffusion (increased signal on diffusion-weighted imaging [DWI] and reduced apparent diffusion coefficient [ADC]) in the cortical ribbon, hippocampus, or thalamus (especially the pulvinar) [
         <a href="#rid67">
          67
         </a>
         ]; contrast enhancement in the same regions; focal or regional increased (18)F-2-fluoro-2-deoxy-D-glucose (FDG) cortical uptake on brain PET [
         <a href="#rid68">
          68,69
         </a>
         ]; cortical vein hyperoxygenation on susceptibility-weighted MRI (SWI) [
         <a href="#rid70">
          70,71
         </a>
         ]; and focal cortical hyperperfusion on contrast-enhanced [
         <a href="#rid70">
          70
         </a>
         ] or contrast-free [
         <a href="#rid71">
          71,72
         </a>
         ] perfusion MRI, as well as perfusion CT [
         <a href="#rid73">
          73
         </a>
         ]. These changes usually resolve once NCSE is aborted, though some permanent sequelae can occur, both clinically and radiographically. (See
         <a class="medical medical_review" href="/z/d/html/2234.html" rel="external">
          "Magnetic resonance imaging changes related to acute seizure activity"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2228.html" rel="external">
          "Neuroimaging in the evaluation of seizures and epilepsy"
         </a>
         .)
        </p>
        <p>
         The diagnostic accuracy of advanced neuroimaging is unknown, and available data come from small, mostly uncontrolled series. Nonetheless, these advanced techniques can be used in selected complex cases to differentiate NCSE from similar patterns of nonictal nature or at least to decide if a pattern of uncertain significance is associated with signs of potential secondary cerebral injury.
        </p>
        <p class="headingAnchor" id="H1486051007">
         <span class="h2">
          Lumbar puncture
         </span>
         <span class="headingEndMark">
          —
         </span>
         Lumbar puncture should be performed if the clinical presentation is suggestive of an acute central nervous system infection, if there is suspicion for subarachnoid hemorrhage despite negative neuroimaging, or if neuroimaging studies raise concern for an alternative infectious or neoplastic process such as leptomeningeal cancer, meningitis, or encephalitis. Lumbar puncture should only be performed after a space-occupying brain lesion has been excluded by appropriate neuroimaging studies, usually a CT head.
        </p>
        <p class="headingAnchor" id="H838198240">
         <span class="h2">
          Electroencephalography
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of NCSE requires EEG.
        </p>
        <p class="headingAnchor" id="H76178">
         <span class="h3">
          Patient selection for EEG
         </span>
         <span class="headingEndMark">
          —
         </span>
         EEG, preferably continuous EEG (cEEG), should be performed routinely in certain clinical situations that are associated with NCSE [
         <a href="#rid2">
          2
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Fluctuating or unexplained alteration in behavior or mental status
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Acute supratentorial brain injury with altered level of consciousness
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Persisting alteration in mental status following treatment of generalized convulsive status epilepticus
         </strong>
         – Patients who present with generalized convulsive status epilepticus are typically expected to awaken gradually after the motor features of seizures disappear. If the level of consciousness is not improving by 10 minutes after cessation of movements, or the mental status remains abnormal 30 to 60 minutes after the convulsions cease, NCSE must be considered and urgent EEG is advised. NCSE can also occur after a single brief convulsion [
         <a href="#rid74">
          74
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In one study, 14 percent of patients treated (seemingly) successfully for convulsive status epilepticus were in NCSE when EEG was begun; of the patients who underwent cEEG monitoring after convulsive status epilepticus was controlled, 48 percent had nonconvulsive seizures on monitoring [
         <a href="#rid60">
          60
         </a>
         ]. Furthermore, once treatment for status epilepticus has begun, especially with continuous infusions, the vast majority (approximately 90 percent) of breakthrough seizures will be subclinical, with no clinical accompaniment aside from depressed mental status.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Critically ill patients who are obtunded or comatose
         </strong>
         – The diagnosis of NCSE in critically ill patients with obtundation or coma can be challenging, since manifestations are often absent or may consist only of subtle myoclonic limb, facial, or ocular movements, and because the underlying medical or neurologic condition might be deemed sufficient to explain the impaired consciousness. In fact, approximately 75 percent of seizures recorded in critically ill patients are unrecognized at the bedside and can only be diagnosed with EEG [
         <a href="#rid14">
          14,16,36
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Recent clinical seizure (of any duration) without return to baseline
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Postanoxic coma
         </strong>
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Epileptiform activity and/or periodic discharges in the first 30 to 60 minutes of initial rEEG recording
         </strong>
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H477119621">
         <span class="h3">
          Routine and continuous EEG
         </span>
         <span class="headingEndMark">
          —
         </span>
         A routine EEG (rEEG) contains a minimum of 20 minutes of technically-satisfactory recording and the technologist is present at the bedside annotating patient behaviors as well as external stimulations in the environment [
         <a href="#rid75">
          75
         </a>
         ]. cEEG differs from rEEG in that the duration of recording is typically several hours or more, commonly more than 24 hours, and the technologist is only occasionally at the bedside during the recording [
         <a href="#rid76">
          76
         </a>
         ].
        </p>
        <p>
         cEEG is a more sensitive test than is rEEG for the detection of nonconvulsive seizures and NCSE in the critically ill population. One meta-analysis found that the pooled prevalence of seizure was 2.5- to 3-fold greater with cEEG compared with rEEG [
         <a href="#rid77">
          77
         </a>
         ]. Only half of patients will have their first seizure within the first hour of recording, and while most critically ill patients with nonconvulsive seizures have their first seizure within 24 hours of the start of a recording, a substantial minority require 48 hours or longer to detect clinically relevant nonconvulsive seizures [
         <a href="#rid14">
          14
         </a>
         ]. (See
         <a class="local">
          'Duration of EEG monitoring'
         </a>
         below.)
        </p>
        <p>
         Observational evidence suggests that the use of cEEG for critically ill patients increases the detection of seizures and may lead to reduced mortality; however, the evidence that it is cost-effective and improves outcomes is supportive but not yet definitive. After adjustment for patient and hospital characteristics, one large cross-sectional study of &gt;7 million ICU patients found that cEEG used in the critically ill was associated with reduced in-hospital mortality [
         <a href="#rid78">
          78
         </a>
         ]. A similar retrospective study compared use of rEEG with cEEG in &gt;45,000 mechanically ventilated patients. Despite no difference in comorbidities, use of cEEG was associated with lower in-hospital mortality without adding significant cost to the hospital stay [
         <a href="#rid79">
          79
         </a>
         ]. In a pragmatic randomized controlled trial of 364 critically ill adults with impaired consciousness and no recent seizures, recruited during daytime hours only, cEEG recording led to an increased detection rate of seizures and status epilepticus compared with repeated rEEG, but there was no difference between groups in mortality [
         <a href="#rid80">
          80
         </a>
         ]. Despite broad international recommendations in support of the use of cEEG, it remains underutilized particularly in nonacademic affiliated hospitals and in centers outside of the United States [
         <a href="#rid2">
          2,81,82
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H86352882">
         <span class="h3">
          EEG electrode array and placement
         </span>
         <span class="headingEndMark">
          —
         </span>
         We recommend using the full array of electrodes based upon the international 10 to 20 system for detection and management of nonconvulsive seizures in routine clinical care, limiting more simplified EEG techniques to cases where full EEG is not available; when it becomes available, the full array should be used in most cases [
         <a href="#rid76">
          76
         </a>
         ].
        </p>
        <p>
         A full EEG array based upon the international 10-20 system remains the technical standard for the EEG diagnosis and monitoring of nonconvulsive seizures. The application and maintenance of EEG leads can be time consuming in the hospital, however, and efforts to improve efficiency have led to reduced 7-lead or 8-lead "subhairline" arrays [
         <a href="#rid83">
          83
         </a>
         ] and other algorithmic analyses of spectral subparameters using as few as two electrodes [
         <a href="#rid84">
          84
         </a>
         ]. Older literature reported that the sensitivity for detection of ictal and interictal epileptiform abnormalities using a reduced EEG electrode array is significantly lower than the standard full EEG array (39 versus 68 percent) [
         <a href="#rid83">
          83
         </a>
         ]. Specificity is also lost, as artifacts or physiologic nonictal rhythmic patterns are more likely to be misinterpreted as seizures.
        </p>
        <p>
         Many institutions are without in-house EEG technologist coverage after regular clinical hours. EEG caps and headbands have been developed which can be rapidly placed by in-house personnel (eg, residents, fellows, nurses) at times when EEG technologists are not available [
         <a href="#rid85">
          85,86
         </a>
         ]. Even with improved technology in recent years, EEG cap recordings remain more often uninterpretable as compared with the standard of care but may be useful in resource-limited settings [
         <a href="#rid87">
          87
         </a>
         ]. Emerging devices may have better results, and definitely permit much more rapid acquisition of EEG tracings (as short as five minutes) to help diagnose or exclude widespread nonconvulsive SE [
         <a href="#rid88">
          88,89
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3558492509">
         <span class="h3">
          Assessing risk of seizure
         </span>
         <span class="headingEndMark">
          —
         </span>
         The risk of seizure can be estimated using clinical and EEG variables and the 2HELPS2B seizure prediction risk score.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical risk factors and EEG pattern
         </strong>
         – The likelihood of a seizure occurring depends heavily on two clinical risk factors (comatose state, history of acute or remote seizures) and on the presence of a high-risk EEG pattern (eg, lateralized periodic discharges [LPDs], lateralized rhythmic delta activity [LRDA], or other epileptiform abnormalities) during the initial recording [
         <a href="#rid90">
          90,91
         </a>
         ]. In a study that included 665 consecutive cEEGs in critically ill patients, the risk of developing a seizure on monitoring was as high as 64 percent at 72 hours in patients with coma, epileptiform findings on initial EEG, and a history of seizure, whereas the risk was as low as 9 percent in those with no clinical or EEG risk factors [
         <a href="#rid91">
          91
         </a>
         ]. Although there is some variability across studies, the projected risk of seizure when there are no high-risk EEG features declines rapidly over time and is &lt;5 percent at 24 hours, except in patients who are comatose and have had prior seizures [
         <a href="#rid91">
          91-93
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          2HELPS2B score
         </strong>
         – The risk of seizures for patients with critical illness undergoing cEEG may be estimated according to clinical and EEG variables. The 2HELPS2B score is useful in triaging the need for cEEG, particularly in institutions with limited resources. The 2HELPS2B seizure prediction risk score combines six features with point assignments [
         <a href="#rid94">
          94
         </a>
         ]:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Brief potentially ictal rhythmic discharges (BIRDs) – 2 points
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Lateralized periodic discharges, lateralized rhythmic delta activity, or bilateral independent periodic discharges – 1 point
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Frequency of discharge &gt;2 Hz for any periodic or rhythmic pattern – 1 point
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Presence of "plus" features (ie, superimposed rhythmic, sharp, or fast activity) – 1 point
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Sporadic epileptiform discharges – 1 point
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Prior clinical seizure (remote or acute) – 1 point
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         In the initial derivation study of the 2HELPS2B model, the risk of seizures increased with the total score: 5 percent for a score of 0, 12 percent for a score of 1, 27 percent for a score of 2, 50 percent for a score of 3, 73 percent for a score of 4, 88 percent for a score of 5, and &gt;95 percent for a score of 6 or 7 [
         <a href="#rid94">
          94
         </a>
         ]. In a later study, the same investigators validated the score in an independent cohort and determined that a one-hour EEG was adequate for calculating the 2HELPS2B score [
         <a href="#rid95">
          95
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2374563133">
         <span class="h3">
          Duration of EEG monitoring
         </span>
         <span class="headingEndMark">
          —
         </span>
         Monitoring duration should be individualized [
         <a href="#rid76">
          76,96
         </a>
         ]. The goal of monitoring is to facilitate early identification and treatment of NCSE; the clinical utility of detecting isolated, infrequent subclinical seizures has not been well established.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients without high-risk clinical features, 24 hours of cEEG recording is a reasonable screen for nonconvulsive seizures, provided no epileptiform discharges emerge. Even shorter time periods are reasonable if cEEG remains negative for several hours and resources are limited [
         <a href="#rid91">
          91
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         For example, one study found that if the 2HELPS2B score is zero (ie, never had a clinical seizure and no epileptiform findings in the first hour of EEG), one hour of EEG without seizures is adequate to conclude that seizures are unlikely (&lt;5 percent chance) to occur with longer monitoring; 3.3 hours of negative EEG would lead to a &lt;2 percent chance of detecting seizures with further monitoring. If the 2HELPS2B score is 1 (ie, any epileptiform findings are seen, or if the patient has ever had a clinical seizure, but not both), at least 12 hours of negative EEG are necessary to reach 95 percent certainty of not detecting seizures, and 29 hours are necessary to reach 98 percent certainty.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients with a 2HELPS2B score of 2 or higher, longer recording is required (always &gt;24 hours).
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         For patients with epileptiform discharges, especially if discharges are periodic, and in patients who are comatose and have a history of prior seizures, prolonged recording (up to 72 hours) is recommended [
         <a href="#rid95">
          95
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1632442840">
         <span class="h1">
          DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The diagnosis of NCSE requires EEG, since the clinical signs and symptoms are pleomorphic and nonspecific [
         <a href="#rid97">
          97,98
         </a>
         ]. In some cases an intravenous (IV) antiseizure medication trial is also required to help determine the significance of uncertain EEG patterns.
        </p>
        <p>
         The criteria for diagnosing NCSE in adults have largely focused on EEG patterns, combined with an acute IV antiseizure medication trial for patients in whom the diagnosis is in doubt. However, the ultimate interpretation of ictal versus nonictal epileptiform activity often remains unclear, even with expert EEG interpretation and proper antiseizure medication trials, particularly in critically ill patients.
        </p>
        <p>
         Prolonged electrographic seizure activity can take several forms, some of which clearly denote NCSE and some of which are more difficult to interpret, probably denoting NCSE only in some cases [
         <a href="#rid99">
          99
         </a>
         ]. (See
         <a class="local">
          'Uncertain EEG patterns in critical illness'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H2396853613">
         <span class="h2">
          EEG patterns of definite NCSE
         </span>
         <span class="headingEndMark">
          —
         </span>
         EEG during NCSE is characterized by frequent seizures or continuous ictal activity corresponding to any of the following patterns [
         <a href="#rid97">
          97,99-102
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In patients without known epileptic encephalopathy:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Focal or generalized spikes, sharp waves, or sharp-and-slow complexes at frequencies averaging &gt;2.5 Hz (ie, &gt;25 epileptiform discharges in 10 seconds)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Focal or generalized spikes, sharp waves, or sharp-and-slow complexes at frequencies ≤2.5 Hz or rhythmic activity &gt;0.5 Hz and one of the following:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Electrographic
         <strong>
          and
         </strong>
         clinical improvement after an IV trial of an antiseizure medication  (
         <a class="graphic graphic_table graphicRef88654" href="/z/d/graphic/88654.html" rel="external">
          table 3
         </a>
         )
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Subtle clinical ictal phenomena during the EEG pattern
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         Typical spatiotemporal evolution, including incrementing onset (increase in voltage and change in frequency), or evolution in pattern (change in frequency &gt;1 Hz or change in location), or decrementing termination (voltage or frequency)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In patients with chronic epilepsy and an epileptic encephalopathy/syndrome:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Frequent or continuous generalized spike-wave discharges, which show significant changes in intensity or frequency (usually a faster frequency) when compared with baseline EEG
        </p>
        <p>
        </p>
        <p>
         To qualify as NCSE, ictal activity should be present for &gt;20 percent of an hour of recording (ie, &gt;12 mins of ictal EEG activity in an hour) in patients with coma or encephalopathy [
         <a href="#rid3">
          3
         </a>
         ]; there is evidence that the risk of neurologic worsening increases significantly when the seizure burden is &gt;20 percent [
         <a href="#rid4">
          4
         </a>
         ]. Some have used a higher threshold requiring that the ictal pattern should be present either for 10 continuous minutes or more than 30 total minutes of ictal EEG activity in any given hour of recording (ie, &gt;50 percent of the record). One study found that this threshold had the best diagnostic accuracy (93 percent) for NCSE, as retrospectively ascertained by a consensus of clinicians based on all the available clinical information [
         <a href="#rid103">
          103
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H907117502">
         <span class="h2">
          Uncertain EEG patterns in critical illness
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are many patterns that may represent seizures in a given scenario or patient, but do not qualify as definite seizures using the above definition. This phenomenon led to the concept of an ictal-interictal continuum, a term that is formally defined by the American Clinical Neurophysiology Society (ACNS) as "a pattern that does not qualify as definite seizure, but there is a reasonable chance that it may be contributing to impaired alertness, causing other clinical symptoms, and/or contributing to neuronal injury" [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
         In critically ill patients and in the aftermath of convulsive status epilepticus, it is common to see these types of EEG patterns, which include a range of periodic or rhythmic discharges (PDs) that do not meet formal seizure criteria. The ACNS initially published a 2012 guideline with standardized nomenclature for these patterns [
         <a href="#rid104">
          104
         </a>
         ], and this was revised and expanded in 2021 [
         <a href="#rid3">
          3
         </a>
         ]. The nomenclature, an abbreviated "pocket" version, a reference chart, a training module, and a certification test are all available on the
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.acns.org%2Fpractice%2Fguidelines&amp;token=IQxLzDq4doJGUgaZgeIY07zyFqVSnwCp0uwoR%2FyUIz5yhVRuhgTu9bQAkzcjpIb4rwC1JCwUsNIWoeWxLU0oqw%3D%3D&amp;TOPIC_ID=14103" target="_blank">
          ACNS website
         </a>
         .
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Types of
         </strong>
         <strong>
          PDs
         </strong>
         – PDs are repetitive stereotyped waveforms of relatively uniform morphology and duration with a clearly discernible interdischarge interval between consecutive waveforms and recurrence of the waveform at nearly regular intervals. PDs may be:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Generalized periodic discharges (GPDs, previously known as GPEDs), which are bilaterally synchronous and symmetric  (
         <a class="graphic graphic_waveform graphicRef94773" href="/z/d/graphic/94773.html" rel="external">
          waveform 2
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Lateralized periodic discharges (LPDs, previously known as PLEDs)  (
         <a class="graphic graphic_waveform graphicRef94774" href="/z/d/graphic/94774.html" rel="external">
          waveform 3
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Bilateral independent discharges (BIPDs, previously known as BIPLEDs), which are present in each hemisphere but independent and at different frequencies  (
         <a class="graphic graphic_waveform graphicRef94775" href="/z/d/graphic/94775.html" rel="external">
          waveform 4
         </a>
         )
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Multifocal periodic discharges (MfPDs), with ≥3 independent locations simultaneously with at least one in each hemisphere
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Unilateral independent periodic discharges (UIPDs), indicating two independent populations of periodic discharges in the same hemisphere
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         PDs often lie on an ictal/interictal continuum [
         <a href="#rid105">
          105
         </a>
         ] and in isolation do not meet formal seizure criteria unless they are &gt;2.5 Hz for &gt;10 seconds (in which case they qualify as electrographic seizures) or have a clear, time-locked clinical correlate (in which case they qualify as electroclinical seizures). Their exact nature and significance are poorly understood, although certain features correlate with NCSE in grouped data (eg, longer GPD duration, higher GPD amplitude, and higher inter-GPD amplitude).
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          GPDs
         </strong>
         – GPDs are often observed in critically ill patients  (
         <a class="graphic graphic_waveform graphicRef94773" href="/z/d/graphic/94773.html" rel="external">
          waveform 2
         </a>
         ) [
         <a href="#rid106">
          106
         </a>
         ]. In a single-center review of over 3000 continuous EEG (cEEG) recordings, GPDs were present in 4.5 percent of patients and correlated with nonconvulsive seizures and NCSE [
         <a href="#rid107">
          107
         </a>
         ]. Specifically, 27 percent of patients with GPDs had evidence of nonconvulsive seizures elsewhere in the same recording, compared with 8 percent of critically ill matched controls without GPDs. Although GPDs have also been described as a postictal pattern after convulsive status epilepticus, they were not associated with convulsive seizures or convulsive status in this study. The presence of GPDs on an EEG does not usually help to determine etiology or prognosis [
         <a href="#rid108">
          108
         </a>
         ], and whether patients will benefit from treatment of these EEG findings (including intermittent, brief nonconvulsive seizures) is uncertain. However, in the TELSTAR trial of 172 patients with post-anoxic coma, treatment of rhythmic and periodic EEG patterns with antiseizure medications did not improve outcomes [
         <a href="#rid109">
          109
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/129547.html" rel="external">
          "Nonconvulsive status epilepticus: Treatment and prognosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         GPDs at a frequency of greater than 1 Hz sometimes signify NCSE. A similar pattern with triphasic morphology can be seen in toxic-metabolic encephalopathy, historically termed "triphasic waves". However, studies of GPDs with triphasic morphology investigated blindly with multiple expert reviewers have called into question its relationship with metabolic encephalopathy and its lack of a relationship with seizures [
         <a href="#rid110">
          110
         </a>
         ]. In fact, a significant minority of patients with these patterns improve neurologically with intravenous antiseizure medications [
         <a href="#rid111">
          111
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         <strong>
          Lateralized periodic or rhythmic patterns
         </strong>
         – Seen in critical illness, lateralized patterns such as LPDs, lateralized rhythmic delta activity (LRDA), and BIPDs have been associated with NCSE elsewhere in the recording but are not clearly indicative of seizures in isolation [
         <a href="#rid14">
          14-16
         </a>
         ]. For LRDA and GPDs, the risk of seizure elsewhere in the recording correlates with higher frequencies (&gt;1.5 Hz) and higher burden of discharges [
         <a href="#rid90">
          90
         </a>
         ]. In some cases, these patterns are more likely to be ictal:
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         LPDs associated with low-voltage rhythmic discharges &gt;4 Hz, referred to as LPDs plus (LPDs+, previously called PLEDs plus), are often associated with seizures  (
         <a class="graphic graphic_waveform graphicRef94776" href="/z/d/graphic/94776.html" rel="external">
          waveform 5
         </a>
         ) [
         <a href="#rid106">
          106,112
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         When LPDs or rhythmic delta are superimposed and fluctuating in frequency, or when periodic discharges reach frequencies ≥1.5 Hz, these patterns are suspicious for seizures and considered to be on the ictal-interictal continuum [
         <a href="#rid3">
          3,68,113,114
         </a>
         ], defined as "a pattern that does not qualify as definite seizure, but there is a reasonable chance that it may be contributing to impaired alertness, causing other clinical symptoms, and/or contributing to neuronal injury" [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent3">
         <span class="glyph">
          -
         </span>
         PDs or any other pattern that is associated with positive signs and symptoms (eg, subtle motor activity, hallucinations, confusion) or negative signs and symptoms (eg, aphasia, cortical blindness) are by definition ictal [
         <a href="#rid115">
          115,116
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          SIRPIDs
         </strong>
         – Stimulus-induced rhythmic periodic, or ictal discharges (SIRPIDs), such as those provoked by suctioning, examination, or loud noise, are a common EEG feature in critically ill patients  (
         <a class="graphic graphic_waveform graphicRef94777" href="/z/d/graphic/94777.html" rel="external">
          waveform 6
         </a>
         ). SIRPIDs usually last for a few minutes but can be shorter or longer depending upon the amount of ongoing stimulation. Some SIRPIDs have a rhythmic, evolving ictal pattern and others do not [
         <a href="#rid117">
          117
         </a>
         ]. SIRPIDs (other than generalized rhythmic delta activity, which is not associated with seizures) are associated with a greater chance for finding electrographic seizures elsewhere in the recording but are not independently associated with increased mortality [
         <a href="#rid118">
          118
         </a>
         ]. The fact that they are stimulus-induced does not alter the association with seizures (in fact, some are stimulus-induced seizures themselves) or the potential for neuronal injury; the risk appears to be the same whether the pattern is stimulus-induced or spontaneous [
         <a href="#rid90">
          90
         </a>
         ]. Thus, the specific pattern is more important than the fact that it is stimulus-induced.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H627169">
         <span class="h2">
          Diagnostic IV antiseizure medication trial
         </span>
         <span class="headingEndMark">
          —
         </span>
         When diagnostic uncertainty persists despite ongoing cEEG, one strategy for distinguishing ictal from nonictal EEG patterns, and for addressing equivocal patterns on the ictal-interictal continuum [
         <a href="#rid68">
          68,113,114
         </a>
         ], is to determine if both the pattern is abolished and the clinical state of the patient improves after a trial of an intravenous (IV) antiseizure medication [
         <a href="#rid106">
          106
         </a>
         ]. In particular, we suggest an IV antiseizure medication trial for cases of suspected NCSE in which the EEG shows repetitive generalized or focal spikes, sharp waves, or spike-and-wave complexes at ≤2.5 Hz that do not have a clear evolution in frequency, morphology, or location  (
         <a class="graphic graphic_table graphicRef88654" href="/z/d/graphic/88654.html" rel="external">
          table 3
         </a>
         and
         <a class="graphic graphic_waveform graphicRef94771" href="/z/d/graphic/94771.html" rel="external">
          waveform 7
         </a>
         ).
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Administering the trial
         </strong>
         – An IV antiseizure medication trial is typically performed by a neurologist or epileptologist with proper nursing support and monitoring of vital signs (ie, electrocardiogram [ECG], blood pressure, pulse oximetry). Although an IV benzodiazepine has traditionally been used, the sedating effect of benzodiazepines makes it hard to determine whether a patient who does not wake up after the trial is still sedated due to the benzodiazepine or is still obtunded due to ongoing seizures or some other central nervous system process.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         We now prefer sequential doses of a nonsedating IV antiseizure medication for the same purpose, such as
         <a class="drug drug_general" data-topicid="8480" href="/z/d/drug information/8480.html" rel="external">
          fosphenytoin
         </a>
         (5 to 10 mg/kg IV),
         <a class="drug drug_general" data-topicid="10035" href="/z/d/drug information/10035.html" rel="external">
          valproate
         </a>
         (20 mg/kg IV),
         <a class="drug drug_general" data-topicid="9904" href="/z/d/drug information/9904.html" rel="external">
          levetiracetam
         </a>
         (20 to 40 mg/kg IV),
         <a class="drug drug_general" data-topicid="106990" href="/z/d/drug information/106990.html" rel="external">
          brivaracetam
         </a>
         (100 to 200 mg IV), or
         <a class="drug drug_general" data-topicid="10268" href="/z/d/drug information/10268.html" rel="external">
          lacosamide
         </a>
         (200 mg IV) [
         <a href="#rid111">
          111,119
         </a>
         ]. If one dose does not have an effect on the EEG or patient, it can usually be repeated quickly.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If using a benzodiazepine,
         <a class="drug drug_general" data-topicid="9650" href="/z/d/drug information/9650.html" rel="external">
          midazolam
         </a>
         is preferred in diagnostic cases because of its rapidly acting pharmacodynamic properties, as well as its short half-life. Sequential 1 mg doses of midazolam are slowly infused intravenously while monitoring the EEG as well as the patient's clinical state, ECG, blood pressure, respirations, and oxygen saturation, up to a maximum dose of approximately 0.2 mg/kg. If IV
         <a class="drug drug_general" data-topicid="9573" href="/z/d/drug information/9573.html" rel="external">
          lorazepam
         </a>
         is used, we suggest 0.5 mg incremental doses (maximum 4 mg). After each dose, a new EEG and neurologic assessment is initiated, and the trial is stopped if there has been definite improvement in either of these two variables, or if there is evidence of respiratory depression or hypotension. This multiple small-step approach is stressed in order to avoid oversedation and consequently missing the window to make the diagnosis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definitive diagnosis
         </strong>
         – NCSE cannot be definitively diagnosed simply based on the resolution of an EEG pattern without clinical improvement, which is the most common result if one large bolus of benzodiazepine is given. Clinical improvement typically takes hours in critically ill patients. The test is only considered diagnostic for NCSE if there has been a substantial improvement in the clinical state or if there has been a return of normal EEG rhythms (eg, posterior-dominant "alpha" rhythm)  (
         <a class="graphic graphic_table graphicRef88654" href="/z/d/graphic/88654.html" rel="external">
          table 3
         </a>
         ). No conclusion can be reached if the EEG pattern resolves but the patient does not improve, and this should be considered possible NCSE or possible electroclinical SE [
         <a href="#rid3">
          3,100
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Definitive positive results with a benzodiazepine trial, including the requirement for a substantial improvement in level of consciousness, were reported in 35 percent of 62 cases in one study [
         <a href="#rid119">
          119
         </a>
         ]. In another study of 64 patients with unexplained encephalopathy and "triphasic-wave EEG patterns of uncertain significance," positive results (defined as resolution of the EEG pattern
         <strong>
          and
         </strong>
         either unequivocal improvement in encephalopathy or the appearance of previously absent normal EEG patterns [eg, posterior dominant rhythm]) were reported in 19 percent of 53 benzodiazepine trials and 27 percent of 45 nonsedating IV antiseizure medication trials; an additional 16 percent had a delayed but possible response [
         <a href="#rid111">
          111
         </a>
         ]. Overall, 34 percent had a definite positive response, and an additional 11 percent had a possible positive response.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4279030791">
         <span class="h2">
          Electroclinical clustering of NCSE subtypes
         </span>
         <span class="headingEndMark">
          —
         </span>
         NCSE is highly heterogenous in its electroclinical features, underlying etiologies, and treatment responsiveness. Still, phenotypic clusters have been suggested by some investigators, such as these three subtypes differentiated by their Glasgow Coma Scale (GCS) score  (
         <a class="graphic graphic_table graphicRef81854" href="/z/d/graphic/81854.html" rel="external">
          table 4
         </a>
         ), EEG pattern, NCSE etiology, and treatment response [
         <a href="#rid120">
          120
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A group with GCS scores of 3 to 8 in the presence of spontaneous burst suppression on EEG with acute symptomatic etiology (eg, within one week of stroke or traumatic brain injury, in the active presence of encephalitis or severe metabolic derangements) and treatment super-refractoriness
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A second group with GCS scores of 9 to 12, presence of LPDs or GPDs on EEG, unknown etiology, and treatment refractoriness
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A third group associated with GCS scores of 13 to 15, absence of LPDs, GPDs, and spontaneous burst suppression on EEG, and progressive and remote symptomatic etiology (eg, prior stroke, tumor) with treatment responsiveness
        </p>
        <p>
        </p>
        <p>
         Prospective studies are required to externally validate the predictive accuracy of this cluster analysis to determine whether this is a clinically useful paradigm. (See
         <a class="medical medical_review" href="/z/d/html/129547.html" rel="external">
          "Nonconvulsive status epilepticus: Treatment and prognosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2107983">
         <span class="h1">
          DIFFERENTIAL DIAGNOSIS
         </span>
         <span class="headingEndMark">
          —
         </span>
         The dominant clinical feature in most forms of NCSE is altered consciousness; therefore, the differential diagnosis of NCSE is broad and overlaps significantly with that of delirium, toxic-metabolic encephalopathy, and drug intoxication or withdrawal, which are discussed in detail separately. (See
         <a class="medical medical_review" href="/z/d/html/4824.html" rel="external">
          "Diagnosis of delirium and confusional states"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1661.html" rel="external">
          "Acute toxic-metabolic encephalopathy in adults"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5104.html" rel="external">
          "Stupor and coma in adults"
         </a>
         .)
        </p>
        <p>
         Psychogenic nonepileptic status epilepticus (PNESE) and psychiatric disorders are also considerations in the differential diagnosis. Continuous video-EEG monitoring is generally required to establish the diagnosis of PNESE in a patient with clinical manifestations that are suggestive of the diagnosis. (See
         <a class="medical medical_review" href="/z/d/html/2227.html" rel="external">
          "Psychogenic nonepileptic seizures: Etiology, clinical features, and diagnosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/2230.html" rel="external">
          "Nonepileptic paroxysmal disorders in adolescents and adults"
         </a>
         .)
        </p>
        <p>
         Neurologic conditions in the differential diagnosis include postictal state, stroke or transient ischemic attack (TIA), transient global amnesia, migraine with aura, concussion and traumatic brain injury, and central nervous system infection [
         <a href="#rid30">
          30
         </a>
         ].
        </p>
        <p>
         Many of the conditions in the differential diagnosis of NCSE are also potential causes of NCSE. As a general rule, EEG should be obtained to rule out NCSE in most patients with altered consciousness, even when an alternative cause of altered consciousness is found, such as a toxic-metabolic encephalopathy or structural brain lesion (eg, intracranial hemorrhage or central nervous system infection); these features are themselves risk factors for seizures. Thus, an EEG is usually warranted to rule out concomitant NCSE as well [
         <a href="#rid38">
          38
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3788750709">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/113971.html" rel="external">
          "Society guideline links: Seizures and epilepsy in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H28783656">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nonconvulsive status epilepticus (NCSE) can be defined as a condition of ongoing or intermittent seizure activity without convulsions, without recovery of consciousness between attacks, and lasting more than 10 minutes; or ictal EEG activity occupying &gt;20 percent of any hour. (See
         <a class="local">
          'Definition'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The underlying causes of NCSE are varied and differ according to the patient population being studied (eg, ambulatory versus critically ill). Approximately one-half to two-thirds of patients will have a prior history of seizures or epilepsy. In the critically ill, common underlying diagnoses include subarachnoid hemorrhage, traumatic brain injury, stroke, and hypoxia/anoxia. (See
         <a class="local">
          'Etiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Impairment of consciousness ranging from mild confusion to coma is usually present in NCSE; focal status epilepticus without impairment in consciousness is less common. Other clinical features of NCSE  (
         <a class="graphic graphic_table graphicRef88652" href="/z/d/graphic/88652.html" rel="external">
          table 2
         </a>
         ) can vary widely and include negative symptoms (eg, mutism, amnesia and catatonia) or positive symptoms (eg, rhythmic twitching of one or more muscle groups, tonic eye deviation, hippus, or nystagmus). (See
         <a class="local">
          'Clinical features'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The International League Against Epilepsy (ILAE) provides a framework for classification of NCSE. The classification has utility for both management and prognosis. (See
         <a class="local">
          'Electroclinical classification'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Nonconvulsive seizures and NCSE are recognized with increasing frequency, both in ambulatory patients with cognitive change, and even more so in the critically ill. The clinical signs and symptoms of NCSE are nonspecific. Any fluctuating or unexplained alteration in behavior or mental status warrants consideration of NCSE and evaluation with EEG, as does any acute supratentorial brain injury with altered level of consciousness. Basic laboratory studies include blood glucose. Neuroimaging is indicated in all patients with unexplained change in mental status; EEG is essential to the evaluation of patients with suspected NCSE. (See
         <a class="local">
          'Evaluation'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Continuous EEG is a more sensitive test than is routine EEG for the detection of nonconvulsive seizures and NCSE. For patients with epileptiform discharges, especially if discharges are periodic, and in patients who are comatose and have a history of prior seizures, prolonged recording (&gt;24 hours) is recommended. (See
         <a class="local">
          'Electroencephalography'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The diagnosis of NCSE requires EEG. The EEG patterns of definite NCSE are described above. (See
         <a class="local">
          'EEG patterns of definite NCSE'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In the aftermath of convulsive status epilepticus and in the critically ill, EEG findings include a range of periodic or rhythmic discharges (PDs) that do not meet formal seizure criteria, but may be ictal in some cases, and may be associated with nonconvulsive seizures elsewhere in the recording. (See
         <a class="local">
          'Uncertain EEG patterns in critical illness'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         A trial of a fast-acting intravenous (IV) antiseizure medication is required in some cases when the EEG pattern is in doubt (ie, ictal versus nonictal), during which the clinician is looking for significant improvement in the EEG and either improved clinical state or return of normal EEG patterns. (See
         <a class="local">
          'Diagnostic IV antiseizure medication trial'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1714620779">
         <span class="h1">
          ACKNOWLEDGMENT
         </span>
         <span class="headingEndMark">
          —
         </span>
         The UpToDate editorial staff acknowledges Nicolas Gaspard, MD, PhD, who contributed to an earlier version of this topic review.
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Trinka E, Cock H, Hesdorffer D, et al. A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus. Epilepsia 2015; 56:1515.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brophy GM, Bell R, Claassen J, et al. Guidelines for the evaluation and management of status epilepticus. Neurocrit Care 2012; 17:3.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hirsch LJ, Fong MWK, Leitinger M, et al. American Clinical Neurophysiology Society's Standardized Critical Care EEG Terminology: 2021 Version. J Clin Neurophysiol 2021; 38:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Payne ET, Zhao XY, Frndova H, et al. Seizure burden is independently associated with short term outcome in critically ill children. Brain 2014; 137:1429.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bilo L, Pappatà S, De Simone R, Meo R. The syndrome of absence status epilepsy: review of the literature. Epilepsy Res Treat 2014; 2014:624309.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Brigo F, Tavernelli V, Nardone R, Trinka E. De novo late-onset absence status epilepticus or late-onset idiopathic generalized epilepsy? A case report and systematic review of the literature. Epileptic Disord 2018; 20:123.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yeo LL, Paliwal PR, Tambyah PA, et al. Complex partial status epilepticus associated with adult H1N1 infection. J Clin Neurosci 2012; 19:1728.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bayreuther C, Bourg V, Dellamonica J, et al. Complex partial status epilepticus revealing anti-NMDA receptor encephalitis. Epileptic Disord 2009; 11:261.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsai MH, Lee LH, Chen SD, et al. Complex partial status epilepticus as a manifestation of Hashimoto's encephalopathy. Seizure 2007; 16:713.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tsuji M, Tanaka H, Yamakawa M, et al. A case of systemic lupus erythematosus with complex partial status epilepticus. Epileptic Disord 2005; 7:249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Marano E, Briganti F, Tortora F, et al. Neurosyphilis with complex partial status epilepticus and mesiotemporal MRI abnormalities mimicking herpes simplex encephalitis. J Neurol Neurosurg Psychiatry 2004; 75:833.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jacobs DA, Fung KM, Cook NM, et al. Complex partial status epilepticus associated with anti-Hu paraneoplastic syndrome. J Neurol Sci 2003; 213:77.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Inoue Y, Fujiwara T, Matsuda K, et al. Ring chromosome 20 and nonconvulsive status epilepticus. A new epileptic syndrome. Brain 1997; 120 ( Pt 6):939.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Claassen J, Mayer SA, Kowalski RG, et al. Detection of electrographic seizures with continuous EEG monitoring in critically ill patients. Neurology 2004; 62:1743.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jette N, Claassen J, Emerson RG, Hirsch LJ. Frequency and predictors of nonconvulsive seizures during continuous electroencephalographic monitoring in critically ill children. Arch Neurol 2006; 63:1750.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pandian JD, Cascino GD, So EL, et al. Digital video-electroencephalographic monitoring in the neurological-neurosurgical intensive care unit: clinical features and outcome. Arch Neurol 2004; 61:1090.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jordan KG. Continuous EEG and evoked potential monitoring in the neuroscience intensive care unit. J Clin Neurophysiol 1993; 10:445.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oddo M, Carrera E, Claassen J, et al. Continuous electroencephalography in the medical intensive care unit. Crit Care Med 2009; 37:2051.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kurtz P, Gaspard N, Wahl AS, et al. Continuous electroencephalography in a surgical intensive care unit. Intensive Care Med 2014; 40:228.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Fugate JE, Kalimullah EA, Hocker SE, et al. Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy. Crit Care 2013; 17:R264.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ekici A, Yakut A, Kural N, et al. Nonconvulsive status epilepticus due to drug induced neurotoxicity in chronically ill children. Brain Dev 2012; 34:824.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Anzellotti F, Ricciardi L, Monaco D, et al. Cefixime-induced nonconvulsive status epilepticus. Neurol Sci 2012; 33:325.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thabet F, Al Maghrabi M, Al Barraq A, Tabarki B. Cefepime-induced nonconvulsive status epilepticus: case report and review. Neurocrit Care 2009; 10:347.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Naeije G, Lorent S, Vincent JL, Legros B. Continuous epileptiform discharges in patients treated with cefepime or meropenem. Arch Neurol 2011; 68:1303.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mazzei D, Accardo J, Ferrari A, Primavera A. Levofloxacin neurotoxicity and non-convulsive status epilepticus (NCSE): a case report. Clin Neurol Neurosurg 2012; 114:1371.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Taupin D, Racela R, Friedman D. Ifosfamide chemotherapy and nonconvulsive status epilepticus: case report and review of the literature. Clin EEG Neurosci 2014; 45:222.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kieslich M, Porto L, Lanfermann H, et al. Cerebrovascular complications of L-asparaginase in the therapy of acute lymphoblastic leukemia. J Pediatr Hematol Oncol 2003; 25:484.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Steeghs N, de Jongh FE, Sillevis Smitt PA, van den Bent MJ. Cisplatin-induced encephalopathy and seizures. Anticancer Drugs 2003; 14:443.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kozak OS, Wijdicks EF, Manno EM, et al. Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome. Neurology 2007; 69:894.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baker AM, Yasavolian MA, Arandi NR. Nonconvulsive status epilepticus: overlooked and undertreated. Emerg Med Pract 2019; 21:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hirsch LJ, Gaspard N, van Baalen A, et al. Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions. Epilepsia 2018; 59:739.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gaspard N, Foreman BP, Alvarez V, et al. New-onset refractory status epilepticus: Etiology, clinical features, and outcome. Neurology 2015; 85:1604.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Khawaja AM, DeWolfe JL, Miller DW, Szaflarski JP. New-onset refractory status epilepticus (NORSE)--The potential role for immunotherapy. Epilepsy Behav 2015; 47:17.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spatola M, Novy J, Du Pasquier R, et al. Status epilepticus of inflammatory etiology: a cohort study. Neurology 2015; 85:464.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Foreman B, Hirsch LJ. Epilepsy emergencies: diagnosis and management. Neurol Clin 2012; 30:11.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kennedy JD, Gerard EE. Continuous EEG monitoring in the intensive care unit. Curr Neurol Neurosci Rep 2012; 12:419.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shorvon S. What is nonconvulsive status epilepticus, and what are its subtypes? Epilepsia 2007; 48 Suppl 8:35.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kinney MO, Kaplan PW. An update on the recognition and treatment of non-convulsive status epilepticus in the intensive care unit. Expert Rev Neurother 2017; 17:987.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Panayiotopoulos CP, Koutroumanidis M, Giannakodimos S, Agathonikou A. Idiopathic generalised epilepsy in adults manifested by phantom absences, generalised tonic-clonic seizures, and frequent absence status. J Neurol Neurosurg Psychiatry 1997; 63:622.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomas P, Valton L, Genton P. Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy. Brain 2006; 129:1281.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Thomas P, Beaumanoir A, Genton P, et al. 'De novo' absence status of late onset: report of 11 cases. Neurology 1992; 42:104.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seshia SS, McLachlan RS. Aura continua. Epilepsia 2005; 46:454.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Bien CG, Elger CE. Epilepsia partialis continua: semiology and differential diagnoses. Epileptic Disord 2008; 10:3.
          </a>
         </li>
         <li class="breakAll">
          Williamson PD, Engel JJ. Complex Partial Seizures. In: Epilepsy: a comprehensive textbook, Engel JJ, Pedley TA (Eds), Lippincott-Raven, Philadelphia 1997. p.557.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Husain AM, Horn GJ, Jacobson MP. Non-convulsive status epilepticus: usefulness of clinical features in selecting patients for urgent EEG. J Neurol Neurosurg Psychiatry 2003; 74:189.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vespa PM, O'Phelan K, Shah M, et al. Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome. Neurology 2003; 60:1441.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Towne AR, Waterhouse EJ, Boggs JG, et al. Prevalence of nonconvulsive status epilepticus in comatose patients. Neurology 2000; 54:340.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shahwan A, Bailey C, Shekerdemian L, Harvey AS. The prevalence of seizures in comatose children in the pediatric intensive care unit: a prospective video-EEG study. Epilepsia 2010; 51:1198.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saengpattrachai M, Sharma R, Hunjan A, et al. Nonconvulsive seizures in the pediatric intensive care unit: etiology, EEG, and brain imaging findings. Epilepsia 2006; 47:1510.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McCoy B, Hahn CD. Continuous EEG monitoring in the neonatal intensive care unit. J Clin Neurophysiol 2013; 30:106.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Carrera E, Claassen J, Oddo M, et al. Continuous electroencephalographic monitoring in critically ill patients with central nervous system infections. Arch Neurol 2008; 65:1612.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abend NS, Gutierrez-Colina AM, Topjian AA, et al. Nonconvulsive seizures are common in critically ill children. Neurology 2011; 76:1071.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kamel H, Betjemann JP, Navi BB, et al. Diagnostic yield of electroencephalography in the medical and surgical intensive care unit. Neurocrit Care 2013; 19:336.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Topjian AA, Gutierrez-Colina AM, Sanchez SM, et al. Electrographic status epilepticus is associated with mortality and worse short-term outcome in critically ill children. Crit Care Med 2013; 41:215.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abend NS, Arndt DH, Carpenter JL, et al. Electrographic seizures in pediatric ICU patients: cohort study of risk factors and mortality. Neurology 2013; 81:383.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laccheo I, Sonmezturk H, Bhatt AB, et al. Non-convulsive status epilepticus and non-convulsive seizures in neurological ICU patients. Neurocrit Care 2015; 22:202.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vespa PM, Nuwer MR, Nenov V, et al. Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring. J Neurosurg 1999; 91:750.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Privitera M, Hoffman M, Moore JL, Jester D. EEG detection of nontonic-clonic status epilepticus in patients with altered consciousness. Epilepsy Res 1994; 18:155.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Claassen J, Jetté N, Chum F, et al. Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology 2007; 69:1356.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DeLorenzo RJ, Waterhouse EJ, Towne AR, et al. Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus. Epilepsia 1998; 39:833.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jaitly R, Sgro JA, Towne AR, et al. Prognostic value of EEG monitoring after status epilepticus: a prospective adult study. J Clin Neurophysiol 1997; 14:326.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Treiman DM, Meyers PD, Walton NY, et al. A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group. N Engl J Med 1998; 339:792.
          </a>
         </li>
         <li class="breakAll">
          Claassen J, Hirsch LJ. Refractory status epilepticus. In: Atlas of Video-EEG Monitoring, Sirven JI, Stern JM (Eds), The McGraw-Hill Companies, Inc., 2011.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Abend NS, Dlugos DJ. Nonconvulsive status epilepticus in a pediatric intensive care unit. Pediatr Neurol 2007; 37:165.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schmitt SE. Utility of Clinical Features for the Diagnosis of Seizures in the Intensive Care Unit. J Clin Neurophysiol 2017; 34:158.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dave HN, Eugene Ramsay R, Khan F, et al. Pyridoxine deficiency in adult patients with status epilepticus. Epilepsy Behav 2015; 52:154.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Szabo K, Poepel A, Pohlmann-Eden B, et al. Diffusion-weighted and perfusion MRI demonstrates parenchymal changes in complex partial status epilepticus. Brain 2005; 128:1369.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Struck AF, Westover MB, Hall LT, et al. Metabolic Correlates of the Ictal-Interictal Continuum: FDG-PET During Continuous EEG. Neurocrit Care 2016; 24:324.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Siclari F, Prior JO, Rossetti AO. Ictal cerebral positron emission tomography (PET) in focal status epilepticus. Epilepsy Res 2013; 105:356.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Verma RK, Abela E, Schindler K, et al. Focal and Generalized Patterns of Cerebral Cortical Veins Due to Non-Convulsive Status Epilepticus or Prolonged Seizure Episode after Convulsive Status Epilepticus - A MRI Study Using Susceptibility Weighted Imaging. PLoS One 2016; 11:e0160495.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Eisele P, Gass A, Alonso A, et al. Susceptibility-weighted MRI signs of compensatory mechanism in nonconvulsive status epilepticus. Neurology 2016; 87:116.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haller S, Zaharchuk G, Thomas DL, et al. Arterial Spin Labeling Perfusion of the Brain: Emerging Clinical Applications. Radiology 2016; 281:337.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           González-Cuevas M, Coscojuela P, Santamarina E, et al. Usefulness of brain perfusion CT in focal-onset status epilepticus. Epilepsia 2019; 60:1317.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tay SK, Hirsch LJ, Leary L, et al. Nonconvulsive status epilepticus in children: clinical and EEG characteristics. Epilepsia 2006; 47:1504.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sinha SR, Sullivan L, Sabau D, et al. American Clinical Neurophysiology Society Guideline 1: Minimum Technical Requirements for Performing Clinical Electroencephalography. J Clin Neurophysiol 2016; 33:303.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Herman ST, Abend NS, Bleck TP, et al. Consensus statement on continuous EEG in critically ill adults and children, part II: personnel, technical specifications, and clinical practice. J Clin Neurophysiol 2015; 32:96.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Limotai C, Ingsathit A, Thadanipon K, et al. How and Whom to Monitor for Seizures in an ICU: A Systematic Review and Meta-Analysis. Crit Care Med 2019; 47:e366.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hill CE, Blank LJ, Thibault D, et al. Continuous EEG is associated with favorable hospitalization outcomes for critically ill patients. Neurology 2019; 92:e9.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ney JP, van der Goes DN, Nuwer MR, et al. Continuous and routine EEG in intensive care: utilization and outcomes, United States 2005-2009. Neurology 2013; 81:2002.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rossetti AO, Schindler K, Sutter R, et al. Continuous vs Routine Electroencephalogram in Critically Ill Adults With Altered Consciousness and No Recent Seizure: A Multicenter Randomized Clinical Trial. JAMA Neurol 2020; 77:1225.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Le Roux P, Menon DK, Citerio G, et al. Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care : a statement for healthcare professionals from the Neurocritical Care Society and the European Society of Intensive Care Medicine. Intensive Care Med 2014; 40:1189.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koffman L, Rincon F, Gomes J, et al. Continuous Electroencephalographic Monitoring in the Intensive Care Unit: A Cross-Sectional Study. J Intensive Care Med 2020; 35:1235.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Young GB, Sharpe MD, Savard M, et al. Seizure detection with a commercially available bedside EEG monitor and the subhairline montage. Neurocrit Care 2009; 11:411.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hernández-Hernández MA, Fernández-Torre JL. Color density spectral array of bilateral bispectral index system: Electroencephalographic correlate in comatose patients with nonconvulsive status epilepticus. Seizure 2016; 34:18.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ladino LD, Voll A, Dash D, et al. StatNet Electroencephalogram: A Fast and Reliable Option to Diagnose Nonconvulsive Status Epilepticus in Emergency Setting. Can J Neurol Sci 2016; 43:254.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yazbeck M, Sra P, Parvizi J. Rapid Response Electroencephalography for Urgent Evaluation of Patients in Community Hospital Intensive Care Practice. J Neurosci Nurs 2019; 51:308.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McKay JH, Feyissa AM, Sener U, et al. Time Is Brain: The Use of EEG Electrode Caps to Rapidly Diagnose Nonconvulsive Status Epilepticus. J Clin Neurophysiol 2019; 36:460.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Westover MB, Gururangan K, Markert MS, et al. Diagnostic Value of Electroencephalography with Ten Electrodes in Critically Ill Patients. Neurocrit Care 2020; 33:479.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Vespa PM, Olson DM, John S, et al. Evaluating the Clinical Impact of Rapid Response Electroencephalography: The DECIDE Multicenter Prospective Observational Clinical Study. Crit Care Med 2020; 48:1249.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rodriguez Ruiz A, Vlachy J, Lee JW, et al. Association of Periodic and Rhythmic Electroencephalographic Patterns With Seizures in Critically Ill Patients. JAMA Neurol 2017; 74:181.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Struck AF, Osman G, Rampal N, et al. Time-dependent risk of seizures in critically ill patients on continuous electroencephalogram. Ann Neurol 2017; 82:177.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Shafi MM, Westover MB, Cole AJ, et al. Absence of early epileptiform abnormalities predicts lack of seizures on continuous EEG. Neurology 2012; 79:1796.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Westover MB, Shafi MM, Bianchi MT, et al. The probability of seizures during EEG monitoring in critically ill adults. Clin Neurophysiol 2015; 126:463.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Struck AF, Ustun B, Ruiz AR, et al. Association of an Electroencephalography-Based Risk Score With Seizure Probability in Hospitalized Patients. JAMA Neurol 2017; 74:1419.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Struck AF, Tabaeizadeh M, Schmitt SE, et al. Assessment of the Validity of the 2HELPS2B Score for Inpatient Seizure Risk Prediction. JAMA Neurol 2020; 77:500.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Herman ST, Abend NS, Bleck TP, et al. Consensus statement on continuous EEG in critically ill adults and children, part I: indications. J Clin Neurophysiol 2015; 32:87.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sutter R, Kaplan PW. Electroencephalographic criteria for nonconvulsive status epilepticus: synopsis and comprehensive survey. Epilepsia 2012; 53 Suppl 3:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaplan PW. The clinical features, diagnosis, and prognosis of nonconvulsive status epilepticus. Neurologist 2005; 11:348.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Walker M, Cross H, Smith S, et al. Nonconvulsive status epilepticus: Epilepsy Research Foundation workshop reports. Epileptic Disord 2005; 7:253.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Beniczky S, Hirsch LJ, Kaplan PW, et al. Unified EEG terminology and criteria for nonconvulsive status epilepticus. Epilepsia 2013; 54 Suppl 6:28.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Jirsch J, Hirsch LJ. Nonconvulsive seizures: developing a rational approach to the diagnosis and management in the critically ill population. Clin Neurophysiol 2007; 118:1660.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leitinger M, Beniczky S, Rohracher A, et al. Salzburg Consensus Criteria for Non-Convulsive Status Epilepticus--approach to clinical application. Epilepsy Behav 2015; 49:158.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Leitinger M, Trinka E, Gardella E, et al. Diagnostic accuracy of the Salzburg EEG criteria for non-convulsive status epilepticus: a retrospective study. Lancet Neurol 2016; 15:1054.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hirsch LJ, LaRoche SM, Gaspard N, et al. American Clinical Neurophysiology Society's Standardized Critical Care EEG Terminology: 2012 version. J Clin Neurophysiol 2013; 30:1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Zafar SF, Subramaniam T, Osman G, et al. Electrographic seizures and ictal-interictal continuum (IIC) patterns in critically ill patients. Epilepsy Behav 2020; 106:107037.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chong DJ, Hirsch LJ. Which EEG patterns warrant treatment in the critically ill? Reviewing the evidence for treatment of periodic epileptiform discharges and related patterns. J Clin Neurophysiol 2005; 22:79.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Foreman B, Claassen J, Abou Khaled K, et al. Generalized periodic discharges in the critically ill: a case-control study of 200 patients. Neurology 2012; 79:1951.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Husain AM, Mebust KA, Radtke RA. Generalized periodic epileptiform discharges: etiologies, relationship to status epilepticus, and prognosis. J Clin Neurophysiol 1999; 16:51.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ruijter BJ, Keijzer HM, Tjepkema-Cloostermans MC, et al. Treating Rhythmic and Periodic EEG Patterns in Comatose Survivors of Cardiac Arrest. N Engl J Med 2022; 386:724.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Foreman B, Mahulikar A, Tadi P, et al. Generalized periodic discharges and 'triphasic waves': A blinded evaluation of inter-rater agreement and clinical significance. Clin Neurophysiol 2016; 127:1073.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           O'Rourke D, Chen PM, Gaspard N, et al. Response Rates to Anticonvulsant Trials in Patients with Triphasic-Wave EEG Patterns of Uncertain Significance. Neurocrit Care 2016; 24:233.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Reiher J, Rivest J, Grand'Maison F, Leduc CP. Periodic lateralized epileptiform discharges with transitional rhythmic discharges: association with seizures. Electroencephalogr Clin Neurophysiol 1991; 78:12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rodríguez V, Rodden MF, LaRoche SM. Ictal-interictal continuum: A proposed treatment algorithm. Clin Neurophysiol 2016; 127:2056.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sivaraju A, Gilmore EJ. Understanding and Managing the Ictal-Interictal Continuum in Neurocritical Care. Curr Treat Options Neurol 2016; 18:8.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pohlmann-Eden B, Hoch DB, Cochius JI, Chiappa KH. Periodic lateralized epileptiform discharges--a critical review. J Clin Neurophysiol 1996; 13:519.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sen-Gupta I, Bernstein RA, Macken MP, et al. Ictal sensory periodic lateralized epileptiform discharges. Epilepsy Behav 2011; 22:796.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hirsch LJ, Claassen J, Mayer SA, Emerson RG. Stimulus-induced rhythmic, periodic, or ictal discharges (SIRPIDs): a common EEG phenomenon in the critically ill. Epilepsia 2004; 45:109.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Braksick SA, Burkholder DB, Tsetsou S, et al. Associated Factors and Prognostic Implications of Stimulus-Induced Rhythmic, Periodic, or Ictal Discharges. JAMA Neurol 2016; 73:585.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hopp JL, Sanchez A, Krumholz A, et al. Nonconvulsive status epilepticus: value of a benzodiazepine trial for predicting outcomes. Neurologist 2011; 17:325.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lattanzi S, Giovannini G, Brigo F, et al. Clinical phenotypes within nonconvulsive status epilepticus. Epilepsia 2021; 62:e129.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 14103 Version 31.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26336950" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : A definition and classification of status epilepticus--Report of the ILAE Task Force on Classification of Status Epilepticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22528274" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Guidelines for the evaluation and management of status epilepticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33475321" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : American Clinical Neurophysiology Society's Standardized Critical Care EEG Terminology: 2021 Version.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24595203" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Seizure burden is independently associated with short term outcome in critically ill children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24660061" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : The syndrome of absence status epilepsy: review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29620008" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : De novo late-onset absence status epilepticus or late-onset idiopathic generalized epilepsy? A case report and systematic review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22989792" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Complex partial status epilepticus associated with adult H1N1 infection.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19736168" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Complex partial status epilepticus revealing anti-NMDA receptor encephalitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17600734" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Complex partial status epilepticus as a manifestation of Hashimoto's encephalopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16162435" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : A case of systemic lupus erythematosus with complex partial status epilepticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15145994" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Neurosyphilis with complex partial status epilepticus and mesiotemporal MRI abnormalities mimicking herpes simplex encephalitis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12873758" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : Complex partial status epilepticus associated with anti-Hu paraneoplastic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9217679" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Ring chromosome 20 and nonconvulsive status epilepticus. A new epileptic syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15159471" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Detection of electrographic seizures with continuous EEG monitoring in critically ill patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17172615" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Frequency and predictors of nonconvulsive seizures during continuous electroencephalographic monitoring in critically ill children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15262740" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Digital video-electroencephalographic monitoring in the neurological-neurosurgical intensive care unit: clinical features and outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8308143" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Continuous EEG and evoked potential monitoring in the neuroscience intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19384197" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Continuous electroencephalography in the medical intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24240843" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Continuous electroencephalography in a surgical intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24200036" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22445289" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Nonconvulsive status epilepticus due to drug induced neurotoxicity in chronically ill children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21720898" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Cefixime-induced nonconvulsive status epilepticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19034700" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Cefepime-induced nonconvulsive status epilepticus: case report and review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21987544" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Continuous epileptiform discharges in patients treated with cefepime or meropenem.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22551579" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Levofloxacin neurotoxicity and non-convulsive status epilepticus (NCSE): a case report.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24151171" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Ifosfamide chemotherapy and nonconvulsive status epilepticus: case report and review of the literature.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12794528" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Cerebrovascular complications of L-asparaginase in the therapy of acute lymphoblastic leukemia.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12853886" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Cisplatin-induced encephalopathy and seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17724292" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Status epilepticus as initial manifestation of posterior reversible encephalopathy syndrome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31557430" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Nonconvulsive status epilepticus: overlooked and undertreated.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29399791" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Proposed consensus definitions for new-onset refractory status epilepticus (NORSE), febrile infection-related epilepsy syndrome (FIRES), and related conditions.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26296517" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : New-onset refractory status epilepticus: Etiology, clinical features, and outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26010959" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : New-onset refractory status epilepticus (NORSE)--The potential role for immunotherapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26092915" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Status epilepticus of inflammatory etiology: a cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22284053" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Epilepsy emergencies: diagnosis and management.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22653639" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Continuous EEG monitoring in the intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18329994" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : What is nonconvulsive status epilepticus, and what are its subtypes?
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28829210" id="rid37" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          38 : An update on the recognition and treatment of non-convulsive status epilepticus in the intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9408104" id="rid38" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          39 : Idiopathic generalised epilepsy in adults manifested by phantom absences, generalised tonic-clonic seizures, and frequent absence status.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16513683" id="rid39" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          40 : Absence and myoclonic status epilepticus precipitated by antiepileptic drugs in idiopathic generalized epilepsy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1734289" id="rid40" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          41 : 'De novo' absence status of late onset: report of 11 cases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15730546" id="rid41" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          42 : Aura continua.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18367424" id="rid42" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          43 : Epilepsia partialis continua: semiology and differential diagnoses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18367424" id="rid43" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          44 : Epilepsia partialis continua: semiology and differential diagnoses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12531946" id="rid44" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          45 : Non-convulsive status epilepticus: usefulness of clinical features in selecting patients for urgent EEG.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12743228" id="rid45" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          46 : Acute seizures after intracerebral hemorrhage: a factor in progressive midline shift and outcome.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10668693" id="rid46" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          47 : Prevalence of nonconvulsive status epilepticus in comatose patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20163439" id="rid47" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          48 : The prevalence of seizures in comatose children in the pediatric intensive care unit: a prospective video-EEG study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16981868" id="rid48" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          49 : Nonconvulsive seizures in the pediatric intensive care unit: etiology, EEG, and brain imaging findings.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23545760" id="rid49" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          50 : Continuous EEG monitoring in the neonatal intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19064748" id="rid50" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          51 : Continuous electroencephalographic monitoring in critically ill patients with central nervous system infections.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21307352" id="rid51" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          52 : Nonconvulsive seizures are common in critically ill children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22820998" id="rid52" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          53 : Diagnostic yield of electroencephalography in the medical and surgical intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23164815" id="rid53" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          54 : Electrographic status epilepticus is associated with mortality and worse short-term outcome in critically ill children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23794680" id="rid54" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          55 : Electrographic seizures in pediatric ICU patients: cohort study of risk factors and mortality.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25246236" id="rid55" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          56 : Non-convulsive status epilepticus and non-convulsive seizures in neurological ICU patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10541231" id="rid56" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          57 : Increased incidence and impact of nonconvulsive and convulsive seizures after traumatic brain injury as detected by continuous electroencephalographic monitoring.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7957038" id="rid57" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          58 : EEG detection of nontonic-clonic status epilepticus in patients with altered consciousness.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17893296" id="rid58" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          59 : Electrographic seizures and periodic discharges after intracerebral hemorrhage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9701373" id="rid59" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          60 : Persistent nonconvulsive status epilepticus after the control of convulsive status epilepticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9337142" id="rid60" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          61 : Prognostic value of EEG monitoring after status epilepticus: a prospective adult study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9738086" id="rid61" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          62 : A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9738086" id="rid62" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          63 : A comparison of four treatments for generalized convulsive status epilepticus. Veterans Affairs Status Epilepticus Cooperative Study Group.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17765803" id="rid63" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          64 : Nonconvulsive status epilepticus in a pediatric intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27571047" id="rid64" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          65 : Utility of Clinical Features for the Diagnosis of Seizures in the Intensive Care Unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26418265" id="rid65" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          66 : Pyridoxine deficiency in adult patients with status epilepticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15743871" id="rid66" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          67 : Diffusion-weighted and perfusion MRI demonstrates parenchymal changes in complex partial status epilepticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27169855" id="rid67" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          68 : Metabolic Correlates of the Ictal-Interictal Continuum: FDG-PET During Continuous EEG.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23582605" id="rid68" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          69 : Ictal cerebral positron emission tomography (PET) in focal status epilepticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27486662" id="rid69" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          70 : Focal and Generalized Patterns of Cerebral Cortical Veins Due to Non-Convulsive Status Epilepticus or Prolonged Seizure Episode after Convulsive Status Epilepticus - A MRI Study Using Susceptibility Weighted Imaging.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27378804" id="rid70" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          71 : Susceptibility-weighted MRI signs of compensatory mechanism in nonconvulsive status epilepticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27755938" id="rid71" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          72 : Arterial Spin Labeling Perfusion of the Brain: Emerging Clinical Applications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31166616" id="rid72" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          73 : Usefulness of brain perfusion CT in focal-onset status epilepticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16981867" id="rid73" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          74 : Nonconvulsive status epilepticus in children: clinical and EEG characteristics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27482788" id="rid74" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          75 : American Clinical Neurophysiology Society Guideline 1: Minimum Technical Requirements for Performing Clinical Electroencephalography.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25626777" id="rid75" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          76 : Consensus statement on continuous EEG in critically ill adults and children, part II: personnel, technical specifications, and clinical practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30855328" id="rid76" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          77 : How and Whom to Monitor for Seizures in an ICU: A Systematic Review and Meta-Analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/30504428" id="rid77" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          78 : Continuous EEG is associated with favorable hospitalization outcomes for critically ill patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24186910" id="rid78" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          79 : Continuous and routine EEG in intensive care: utilization and outcomes, United States 2005-2009.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32716479" id="rid79" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          80 : Continuous vs Routine Electroencephalogram in Critically Ill Adults With Altered Consciousness and No Recent Seizure: A Multicenter Randomized Clinical Trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25138226" id="rid80" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          81 : Consensus summary statement of the International Multidisciplinary Consensus Conference on Multimodality Monitoring in Neurocritical Care : a statement for healthcare professionals from the Neurocritical Care Society and the European Society of Intensive Care Medicine.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31084284" id="rid81" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          82 : Continuous Electroencephalographic Monitoring in the Intensive Care Unit: A Cross-Sectional Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19585276" id="rid82" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          83 : Seizure detection with a commercially available bedside EEG monitor and the subhairline montage.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26615579" id="rid83" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          84 : Color density spectral array of bilateral bispectral index system: Electroencephalographic correlate in comatose patients with nonconvulsive status epilepticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26864547" id="rid84" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          85 : StatNet Electroencephalogram: A Fast and Reliable Option to Diagnose Nonconvulsive Status Epilepticus in Emergency Setting.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31688282" id="rid85" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          86 : Rapid Response Electroencephalography for Urgent Evaluation of Patients in Community Hospital Intensive Care Practice.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31335565" id="rid86" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          87 : Time Is Brain: The Use of EEG Electrode Caps to Rapidly Diagnose Nonconvulsive Status Epilepticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32034656" id="rid87" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          88 : Diagnostic Value of Electroencephalography with Ten Electrodes in Critically Ill Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32618687" id="rid88" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          89 : Evaluating the Clinical Impact of Rapid Response Electroencephalography: The DECIDE Multicenter Prospective Observational Clinical Study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27992625" id="rid89" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          90 : Association of Periodic and Rhythmic Electroencephalographic Patterns With Seizures in Critically Ill Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/28681492" id="rid90" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          91 : Time-dependent risk of seizures in critically ill patients on continuous electroencephalogram.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23054233" id="rid91" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          92 : Absence of early epileptiform abnormalities predicts lack of seizures on continuous EEG.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25082090" id="rid92" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          93 : The probability of seizures during EEG monitoring in critically ill adults.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29052706" id="rid93" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          94 : Association of an Electroencephalography-Based Risk Score With Seizure Probability in Hospitalized Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31930362" id="rid94" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          95 : Assessment of the Validity of the 2HELPS2B Score for Inpatient Seizure Risk Prediction.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25626778" id="rid95" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          96 : Consensus statement on continuous EEG in critically ill adults and children, part I: indications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22862158" id="rid96" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          97 : Electroencephalographic criteria for nonconvulsive status epilepticus: synopsis and comprehensive survey.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16286878" id="rid97" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          98 : The clinical features, diagnosis, and prognosis of nonconvulsive status epilepticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16162436" id="rid98" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          99 : Nonconvulsive status epilepticus: Epilepsy Research Foundation workshop reports.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24001066" id="rid99" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          100 : Unified EEG terminology and criteria for nonconvulsive status epilepticus.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17588812" id="rid100" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          101 : Nonconvulsive seizures: developing a rational approach to the diagnosis and management in the critically ill population.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26092326" id="rid101" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          102 : Salzburg Consensus Criteria for Non-Convulsive Status Epilepticus--approach to clinical application.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27571157" id="rid102" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          103 : Diagnostic accuracy of the Salzburg EEG criteria for non-convulsive status epilepticus: a retrospective study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23377439" id="rid103" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          104 : American Clinical Neurophysiology Society's Standardized Critical Care EEG Terminology: 2012 version.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32222672" id="rid104" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          105 : Electrographic seizures and ictal-interictal continuum (IIC) patterns in critically ill patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15805807" id="rid105" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          106 : Which EEG patterns warrant treatment in the critically ill? Reviewing the evidence for treatment of periodic epileptiform discharges and related patterns.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23035068" id="rid106" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          107 : Generalized periodic discharges in the critically ill: a case-control study of 200 patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10082092" id="rid107" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          108 : Generalized periodic epileptiform discharges: etiologies, relationship to status epilepticus, and prognosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35196426" id="rid108" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          109 : Treating Rhythmic and Periodic EEG Patterns in Comatose Survivors of Cardiac Arrest.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26294138" id="rid109" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          110 : Generalized periodic discharges and 'triphasic waves': A blinded evaluation of inter-rater agreement and clinical significance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26013921" id="rid110" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          111 : Response Rates to Anticonvulsant Trials in Patients with Triphasic-Wave EEG Patterns of Uncertain Significance.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1701709" id="rid111" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          112 : Periodic lateralized epileptiform discharges with transitional rhythmic discharges: association with seizures.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26971489" id="rid112" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          113 : Ictal-interictal continuum: A proposed treatment algorithm.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26874841" id="rid113" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          114 : Understanding and Managing the Ictal-Interictal Continuum in Neurocritical Care.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8978624" id="rid114" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          115 : Periodic lateralized epileptiform discharges--a critical review.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22018801" id="rid115" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          116 : Ictal sensory periodic lateralized epileptiform discharges.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/14738418" id="rid116" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          117 : Stimulus-induced rhythmic, periodic, or ictal discharges (SIRPIDs): a common EEG phenomenon in the critically ill.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/26975002" id="rid117" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          118 : Associated Factors and Prognostic Implications of Stimulus-Induced Rhythmic, Periodic, or Ictal Discharges.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22045283" id="rid118" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          119 : Nonconvulsive status epilepticus: value of a benzodiazepine trial for predicting outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34244997" id="rid119" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          120 : Clinical phenotypes within nonconvulsive status epilepticus.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
